What Is a Mood Disorder: Types, Diagnosis, and Treatment Approaches

This article is for informational purposes only. Consult a qualified healthcare professional for medical advice, diagnosis, or treatment.

What Is a Mood Disorder?

Mood disorders are a category of psychiatric conditions characterized by persistent disturbances in a person's emotional state—either depression (low mood), mania/hypomania (elevated or irritable mood), or both in cyclical patterns. They are among the most prevalent and disabling mental health conditions worldwide. The World Health Organization ranks major depressive disorder as one of the leading causes of disability globally, while bipolar disorder is among the top causes of disability in young adults. Mood disorders are distinguished from normal emotional fluctuations by their severity, duration, functional impairment, and frequent requirement for professional treatment.

Classification of Major Mood Disorders

Major Depressive Disorder: Criteria and Features

A major depressive episode requires the presence of five or more of the following symptoms during the same 2-week period (at least one must be depressed mood or loss of interest/pleasure):

• Depressed mood most of the day, nearly every day (subjective or observed)
• Markedly diminished interest or pleasure in all or almost all activities (anhedonia)
• Significant unintentional weight loss or gain, or changes in appetite
• Insomnia or hypersomnia
• Psychomotor agitation or retardation (observable by others, not just subjective)
• Fatigue or loss of energy nearly every day
• Feelings of worthlessness or excessive guilt
• Difficulty concentrating, thinking, or making decisions
• Recurrent thoughts of death or suicide, suicidal ideation, or a suicide attempt

Symptoms must cause significant distress or functional impairment and not be attributable to substance use or a medical condition.

Bipolar Disorder: The Spectrum of Mood Episodes

Bipolar disorder is characterized by episodes of both elevated and depressed mood. A manic episode involves abnormally elevated, expansive, or irritable mood and increased goal-directed activity for at least 7 days (or any duration if hospitalization is required), accompanied by at least 3 of: grandiosity, decreased sleep need, pressured speech, racing thoughts, distractibility, increased goal-directed activity, and excessive risk-taking. Hypomania is a less severe variant lasting at least 4 days that does not cause marked impairment or require hospitalization.

Bipolar I requires at least one manic episode; depressive episodes are common but not required for diagnosis. Bipolar II requires at least one hypomanic and one major depressive episode with no history of full mania. Misdiagnosis of bipolar II as unipolar depression is common and clinically consequential—antidepressant monotherapy without a mood stabilizer can precipitate hypomania or rapid cycling in bipolar patients.

Biological Underpinnings

Mood disorders involve complex interactions between genetic, neurobiological, and environmental factors:

• Genetics: Heritability estimates are approximately 37% for MDD and 60–80% for bipolar disorder. Genome-wide association studies have identified numerous risk loci. A family history of bipolar disorder is the single strongest risk factor for developing it.
• Neurotransmitter systems: The monoamine hypothesis (reduced serotonin, norepinephrine, and dopamine) explains the efficacy of many antidepressants but is an oversimplification. Glutamate dysfunction—particularly NMDA receptor hypofunctioning—is increasingly recognized; ketamine's rapid antidepressant action via NMDA blockade has transformed understanding of depressive neurobiology.
• Neuroendocrine dysregulation: HPA axis hyperactivation (elevated cortisol) is found in severe depression; hypothyroidism can cause or worsen depressive symptoms.
• Neuroinflammation: Elevated inflammatory cytokines (TNF-alpha, IL-6) are found in depression and may contribute to symptom generation, providing a rationale for anti-inflammatory treatment approaches.
• Brain structural changes: Neuroimaging studies show reduced hippocampal volume, prefrontal cortex thinning, and amygdala hyperreactivity in depression; the amygdala and prefrontal-limbic circuit dysregulation is prominent in bipolar disorder.

Treatment Approaches by Disorder Type

Psychotherapy for Mood Disorders

Several evidence-based psychotherapies are effective for mood disorders. Cognitive Behavioral Therapy (CBT) is the most extensively studied, with demonstrated efficacy in MDD comparable to antidepressants in mild-to-moderate cases and superior relapse prevention. Interpersonal Therapy (IPT) focuses on grief, role transitions, and relationship difficulties that contribute to depression. Behavioral Activation specifically targets the withdrawal and avoidance behaviors that maintain depression. Psychoeducation and interpersonal and social rhythm therapy (IPSRT) are specifically designed for bipolar disorder, helping patients regulate daily routines and recognize prodromal symptoms. For bipolar disorder, medication remains essential—psychotherapy is adjunctive rather than a replacement.

Suicide Risk

Mood disorders significantly elevate suicide risk. The lifetime risk of suicide in untreated bipolar disorder has been estimated at approximately 15–20%; the risk is also substantially elevated in severe MDD. Lithium is the only mood stabilizer with evidence for specifically reducing suicidal behavior. Any suicidal ideation should prompt urgent clinical evaluation.